NORGINE PHARMACEUTICALS LIMITED

1. Company facts

Status

active

Lifecycle

🌳 Mature — Long-running with flat or slow growth. Steady cash, limited upside.

Jurisdiction

england-wales

Registered office

Arc Uxbridge Building 01, Sanderson Road, Uxbridge, UB8 1DH, United Kingdom

SIC codes

46460 — SIC 46460

Accounts next due

2026-09-30

Confirmation statement next due

2027-03-27

2. Directors (4 active)

ACKLAND, Katharine Grace

director · appointed 2025-07-04 · born 12/1992 (age 34)

ASHTON, Mark Steven

director · appointed 2022-09-12 · born 1/1978 (age 48)

BARRETO MARTINIANO, Saulo

director · appointed 2023-12-31 · born 12/1972 (age 54)

VAN DER KAMP, Hilde Johanna

director · appointed 2026-03-04 · born 3/1975 (age 51)

3. Shareholders (1 active)

Spinnaker Debtco Limited

75-100% shares · 75-100% voting · board control

4. Group structure

Spinnaker Debtco Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

Spinnaker Debtco Limited

Corporate parent · 75-100%

5. Security

1 total charge (0 outstanding, 1 satisfied).

Headline verdict

Opportunity score

73/100 (Strong)

Owner dependency

moderate — 40/100

Red flags

0 high · 0 medium · 1 low